Thorough QT/De-risking QT for Cardiac Safety

Pharmaron excels in the design and development of cardiac safety studies. Pharmaron’s experienced medical team works closely with our strategic partner, ERT, to deliver high quality ECG data with expert interpretation.

Our team has successfully completed Thorough QT (TQT) and De-risking QT studies for sponsors that were on the critical path in their drug development program, and where on-time delivery of data was paramount to the continuing success of their candidate drug and company.

Learn More: Clinical Development Services Overview